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The basidiomycete Hypholoma sublateritium
produces the triterpenoid antitumor clavaric
acid, an inhibitor of the human Ras-farnesyl
transferase. The H. sublateritium squalene
epoxidase gene (erg1) has been cloned and
shown to encode a flavoprotein monooxy-
genase that requires FAD, NADPH, and P450
cofactors. Silencing of the erg1 gene in H. sub-
lateritium using constructions expressed from
the gdh promoter of Agaricus bisporus showed
that the squalene epoxidase is involved in
clavaric acid formation and in ergosterol bio-
synthesis; silenced expression of erg1 resulted
in an ergosterol-dependent phenotype for full
growth. Overexpression of erg1 gene resulted
in up to 32% to 97% increment of clavaric
acid production confirming its involvement in
the biosynthesis of this antitumor product. Ox-
idosqualene (or dioxidosqualene) appears to
be the branching point for primary metabolism
(sterols) and secondary metabolites in basidio-
mycetes.
INTRODUCTION
Mushrooms have been widely used in traditional medicine
[1]. They produce hundreds of secondary metabolites,
many of themhaving antitumor activity [2, 3]. Fungi, partic-
ularly basidiomycetes, are excellent sources for the
screening of new antitumor agents [2, 4–6]. However,
progress on the elucidation of the biosynthesis of these
metabolites in basidiomycetes has been slow due to the
lack of adequate molecular genetics tools for genemanip-
ulation in those fungi.
Mutant ras genes (oncogenes) are associated with a va-
riety of solid tumors in humans [7]. The Ras proteins RasH,
RasN, RasK-4A, and RasK-4B act as biological switches
that are regulated by GDP and GTP binding. They are
modified posttranslationally by prenylation (introduction
of a lipophilic 15-carbon farnesyl moiety) by the action of1334 Chemistry & Biology 14, 1334–1346, December 2007 ª20the RAS farnesyl transferase (FPTase) [8–10]. The prenyla-
tion of the RAS protein plays an essential role in the uncon-
trolled cell proliferation in tumor cells as compared to nor-
mal cells. Inhibitors of the FPTase have been searched as
candidates for antitumor agents [6, 11].
In 1998, researchers atMerck isolated fromamushroom
a potent inhibitor of the RAS farnesyltransferase that was
named clavaric acid [12, 13]. Although the producer fungi
was initially thought to be Clavariadelphus truncatus,
detailed taxonomic studies showed that it corresponds
to Hypholoma sublateritium (colloquially named ‘‘brick
cap’’) [6]. Clavaric acid is a triterpenoid compound, struc-
turally related to fasciculic acid, a calmodulin inhibitor
produced by Naematoloma (Syn. Hypholoma) fasciculare
[14, 15]. Clavaric acid appears to be synthesized from
the triterpene squalene by a pathway related to ergosterol
biosynthesis involving the enzymes squalene epoxidase
and dioxidosqualene cyclase converting 2,3:22,23-
dioxidosqualene to clavarinone, the putative last interme-
diate in clavaric acid biosynthesis (Figure 1).
Theenzymesqualeneepoxidase (SE) (EC.1.14.99.7) cat-
alyzes the conversion of squalene to (3S)2,3-oxidosqua-
lene (Figure 1). Genes encoding SE involved in sterol bio-
synthesis have been cloned from vertebrates [16, 17],
yeasts, and other ascomycetes [18–22], but very little
information on clavaric acid biosynthesis is available. In
the clavaric acid biosynthesis the SE may also catalyze
a second step converting 2,3-oxidosqualene to 2,3:22,23-
dioxidosqualene.
An important question is whether the SE involved in bio-
synthesis of clavaric acid in H. sublateritium (and other
structural analogs in other basidiomycetes) is different
from the Erg1 protein or not, i.e., if there are separate
SEs for primary and secondary metabolism or if the bio-
synthesis of clavaric acid diverges from that of ergosterol
after the oxidosqualene biosynthetic step. On the other
hand, the last steps of clavaric acid biosynthesis are
clearly different from those involved in lanosterol and
ergosterol biosynthesis. It is therefore of great interest to
clone the genes involved in the last steps of ergosterol
and clavaric acid biosynthesis in H. sublateritium to clarify
these questions. Knowledge of the genetics of clavaric
acid biosynthesis will allow us to understand the biosyn-
thesis of this interesting isoprenoid molecule and to obtain07 Elsevier Ltd All rights reserved
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Clavaric Acid Biosynthesis in HypholomaFigure 1. Proposed Clavaric Acid Biosynthetic Pathway
Clavaric acid derives from the triterpenoid squalene. The squalene epoxidase (monooxygenase) reactions converting squalene to 2,3-oxidosqualene
and 2,3:22,23-dioxidosqualene are boxed. The pathway to ergosterol branches out from 2,3-oxidosqualene. The conversion of 2,3:22,23-dioxidos-
qualene to clavarinone and to clavaric acid are hypothetical reactions (see text for details).higher producing H. sublateritium strains since clavaric
acid is barely available for animal clinical studies.
In this article, we report the cloning, characterization of
the erg1 gene ofH. sublateritium, and the effect of its over-
expression and silencing by antisense RNA on clavaric
acid biosynthesis. Our results indicate that the erg1
gene encodes a squalene epoxidase that is involved in
both ergosterol biosynthesis and clavaric acid production.
RESULTS
Cloning and Sequencing of the erg1 Gene
Encoding the Squalene Epoxidase
of H. sublateritium
A fragment of the erg1 gene ofH. sublateritiumwas cloned
by PCR with degenerated oligonucleotides SE1 and SE2
(Table 1), based on known squalene epoxidase se-
quences, as primers and a range of temperatures from
50C to 70C. A band of about 0.8 kb was obtained that
was cloned in pGEM-T-Easy and sequenced. The nucleo-
tide sequence revealed that it contained a fragment of an
ORF corresponding to a putative squalene epoxidase (the
plasmid was designated pGEM-SE). The cloned fragment
lacked EcoRV restriction sites, and therefore, this enzymeChemistry & Biology 14, 1334–134was used for a complete digestion of total H. sublateritium
DNAtoclonea largerDNA fragmentcontaining theSEgene.
Since an H. sublateritium DNA library was not available
at that time, the DNA regions adjacent to the cloned 0.8 kb
DNA fragment were amplified by inverse PCR with oligo-
nucleotides EPO1 and EPO2 (Table 1) as primers and total
H. sublateritium DNA, digested with EcoRV and self-li-
gated, as template. As the initially cloned DNA fragment
contained a unique NcoI site, the pool of self-ligated
(circularized) EcoRV fragments was digested with NcoI
thus allowing linearization of those plasmids. The primers
EPO1 and EPO2 annealed at the ends of the linearized
fragments and allowed amplification of the EcoRV frag-
ment containing the EPO1 and EPO2 sequences.
This strategy resulted in amplification of a DNA region of
about 3 kb that included the regions adjacent to the 0.8
fragment cloned initially. The entire 3 kb EcoRV fragment
was mapped with restriction endonucleases and se-
quenced. It contained anORF of 1659 bpwith five putative
introns.
To confirm the presence of the introns, cDNA was ob-
tained from RNA of H. sublateritium (18 d static liquid cul-
tures in MEA broth) as template by using oligonucleotides
EX1F, EX1R, EX2F, EX2R, EX5F, and EX5R (Table 1) flank-
ing each of the putative introns as primers. Sequencing of6, December 2007 ª2007 Elsevier Ltd All rights reserved 1335
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contained five introns of 57, 57, 53, 33, and 73 nucleo-
tides, at positions 751–807, 1138–1194, 1281–1333,
1403–1435, and 1530–1602 numbered from the ATG
translation initiation codon. The cloned gene showed an
ORF of 1659 bp and encoded a protein of 461 amino acids
with a deduced molecular weight of 49,079 Da.
The Cloned ORF1 Encodes a Squalene Epoxidase
Searches of the ORF1-encoded protein in the databases
revealed a high similarity with proteins annotated as squa-
lene epoxidases and with proteins of unknown function
deduced from the genomes of different fungi. The highest
similarity was with an unknown protein of Ustilago maydis
(E value = 13 10101) and a protein annotated as squalene
epoxidase of Cryptococcus neoformans (E value = 1 3
1097), both of which are basidiomycetes. When the pro-
tein encoded by ORF1 was aligned with the squalene
epoxidases of ascomycetes [22], the identity ranged
from 33% to 49% (Figure 2B), indicating that the protein
encoded by ORF1 is a squalene epoxidase-like protein,
but the low percentage of identity when compared with
the ascomycetes SEs suggests that it might have a slightly
different substrate specificity.
The squalene epoxidases are FAD-dependent monoox-
ygenases. An analysis of the conserved domains of the
Table 1. Oligonucleotides Used as Primers
Primers
Name Sequence (50/30)
EMBLF5 TTATGCCCGAGAAGATGTT
EPO1 CCTCAAGACAGCCCTCCATTCC
EPO2 AGGGGAAGGACGGGGAAGAGG
EX1F GAGCTCGTCGAGGCGACT
EX1R GAGCTGCGGTACGATGTT
EX2F TACCCATCCAGCGCGCGC
EX2R CCCCCACGCTCGAAGTAC
EX5F GGAAGTGCAAAGCAAGTG
EX5R CCCGAACACGACGCACGC
HPH4 ACTTCTCGACAGACGTCGCGG
PGDHA-F GGAGCTCTTGGAATGGAATTA
PGDHA-R GGGCATGTTGTATATTGGCTG
RTSEF ATGTCCAAATCCCGCTCAA
RTSER CAGATCGCAGGGCGTGAAA
SE1 CCSGACCGSATCGTSGGCGAG
SE2 GTSAGSGGGTGSCGCATGTT
SE4 TACAGGTTTAGGGCGAGTT
SE6 GGAACTCCAGCCGTCCATC
SE14 GGTGGGTGCACAAAATGGAAG
TGDHA-F GGGTAGGCGATTAGTGGAGG
TGDHA-R GGGATCCAGAGAAACTCTGAT1336 Chemistry & Biology 14, 1334–1346, December 2007 ª2Erg1 protein with the Pfam bioinformatic tool (protein fam-
ilies database of alignments, http://www.sanger.ac.uk/
Pfam/) revealed the conservation in Erg1 and other squa-
lene epoxidases of three strictly conserved motifs (two in
the first exon and one in the second exon) (Figure 2A)
known to be involved in FAD binding and squalene recog-
nition (see Discussion).
Genes Flanking the erg1 Gene
In fungi, genes for secondary metabolism are sometimes
scattered in the genome, but frequently they are arranged
in clusters [23, 24]. To study the genes adjacent to erg1,
a phage containing the region around erg1 was isolated
by screening a genomic library of H. sublateritium
HS898 in the EMBL3 phage vector (see Experimental Pro-
cedures) by the PCR procedure of Vaiman [25] by using
oligonucleotides SE1 and SE2 (Table 1) as primers. Three
phages were positives giving an amplification of 0.8 kb
corresponding to an internal fragment of erg1. Phage
F36-2 was selected because the erg1 gene was located
in the center of the insert and sequenced in both DNA
strands. As shown in Figure 3A, the erg1 gene was flanked
upstream by a truncated ORF2 that encodes a putative
epoxide hydrolase and downstream by a putative
a-D-glucosidase.
The putative epoxide hydrolase contains a domain
(a/b fold) characteristic of fungal microsomal epoxide hy-
drolases (pfam00561.13). It is unclear at this time if any of
theseproteinsmaybe involved inclavaricacidbiosynthesis.
Overexpression of erg1 from the Agaricus
bisporus gdhA Promoter Leads to Increased
Clavaric Acid Production
The erg1 genewas overexpressed by using a construction
pGDHA-SEover inwhich theerg1genewascoupled (at the
ATG translation initiation codon) to the A. bisporus gdhA
promoter (cloned for this purpose; see Experimental Pro-
cedures), a regulated promoter (repressed by ammonium
ions andderepressed in asparagine/glutamate-basedme-
dium). The GDHA-SEover cassette for overexpression of
erg1 was then subcloned in the Agrobacterium-Hypho-
loma conjugative plasmid pBGgHg, giving the construc-
tion pHgSEover (Figure 3B) that was used to transform
H. sublateritium HS898 by conjugation.
The presence of the correct expression cassette in the
transformants was confirmed by PCR with primers SE14
(internal to the erg1 gene) and HPH4 (internal to the
hygromycin resistance hph gene in the cassette). A 1.1
kb amplification band (Figure 3C) indicated that the cas-
sette had been integrated without rearrangement. The
wild-type H. sublateritium strain showed a single copy of
the erg1 gene. The presence of at least one additional
copy of the erg1 gene in the transformants was confirmed
by Southern hybridization with a 340 bp probe internal to
the erg1 gene (Figure 3D).
Expression of erg1 in two of the transformants, HS898-
SEover-43 and SEover-21, was tested by northern anal-
yses with total RNA from 15 day static liquid cultures in
minimal medium (MM, Experimental Procedures)007 Elsevier Ltd All rights reserved
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asparagine/glutamate (15 mM) as nitrogen sources. Re-
sults of the northern analyses (Figure 4A) showed that
both transformants formed higher levels of erg1 tran-
script as compared to the untransformed strain in the as-
paragine/glutamate but not in cultures in 30 mM ammo-
nium medium where expression occurs primarily from
the endogenous erg1 gene (unregulated by ammonium)
and not from the ammonium-repressed gdhA cassette.
The effect of erg1 overexpression on clavaric acid pro-
duction was quantified in liquid cultures of both transform-
ants and the control untransformed strain in defined
medium containing either asparagine/glutamate or am-
monium acetate (10 or 30 mM) as nitrogen sources. As
observed in Figure 4B, the yield of clavaric acid of the
transformants increased to 132% and 197% of the pro-
duction of the control strain in the derepressing nitrogen
source, whereas there was only a small increase (to
104% and 119%) in medium with 10 mM ammonium
and no increase at all in medium with 30 mM ammonium
(concentrations that repress expression from theA. bispo-
rus gdh promoter).
Overexpression of erg1 Reduces the Sensitivity
to Terbinafine
A comparative analysis of the resistance to terbinafine [21,
22] showed that transformants SEover-43 and SEover-21
were less sensitive to terbinafine (in the range of 2.5 to
12.5 mg/ml) (not shown) probably because of the in-
creased levels of squalene epoxidase in these two strains.
Transformant SEover-43 showed always 30%–50%
higher growth than transformant SEover-21, at the differ-
ent levels of terbinafine tested, which correlates well
with the level of expression of the erg1 gene in these
two transformants (see Discussion).
Silencing of erg1 Gene Expression by Antisense
RNA Reduces Clavaric Acid Production
Constructions for erg1 gene disruption by gene replace-
ment were made by using plasmid pBS-SKSEI in which
the internal region of erg1was replaced by a cassette con-
taining the hygromycin resistance (hph) gene coupled to
the A. bisporus gpd promoter. After testing 315 transform-
ants by PCR and Southern hybridization, none of the
tested transformants showed the desired gene replace-
ment (not shown) even when the expected recombinants
were grown in presence of ergosterol.
Therefore, silencing of erg1 gene expression by the an-
tisense RNA was used as an alternative strategy [26]; the
constructions for antisense RNA expression (pHg-SEa1
and pBG-SEa2) contained, respectively, a 800 or 1600 bp
fragment of the erg1 gene in the 30-50 orientation ex-
pressed from the nitrogen source-regulated gdhA pro-
moter of A. bisporus and flanked downstream by the
TgdhA transcriptional terminator (Figure 5A). Integration
of the intact antisense expression cassette in the H. sub-
lateritium transformant was tested by PCR with primers
PGDHA-F and TGDHA-R (Table 1) corresponding, re-
spectively, to the A. bisporus gdhA promoter and theChemistry & Biology 14, 1334–134gdhA terminator, as shown in the construction in
Figure 5A.
These primers amplified a DNA fragment of 1.8 kb in the
HS898 SEa1 transformant (67 transformants tested) or of
2.5 kb in the HS898 SEa1 transformants (31 transformants
tested). The correct integration of the antisense expres-
sion cassette was confirmed by Southern hybridization
with, as probe, a 340 bp fragment of the erg1 gene that
was present in the antisense construction. As shown in
Figure 5B, four of these transformants (two with the SEa1
and two with SEa2 constructions) showed the expected
hybridization bands.
Northern analysis of the expression of erg1 in two of the
transformants HS898 SEa1-23 (with the SEa1 antisense
construction) and HS898 SEa2-4 (with the antisense
SEa2 construction) showed (Figure 6A) that there was
a strong reduction (50%) of the expression of erg1 in the
transformants with the antisense constructions in the as-
paragine/glutamate-based medium and a small reduction
of erg1 gene expression in the transformants grown in
medium with 10 mM NH4
+ and no significant reduction
in medium containing 30 mM NH4
+ as nitrogen source
(repressing conditions for the gdhA promoter that drives
the antisense RNA expression).
The reduced expression of erg1 in the transformants
containing the antisense cassette correlated with a de-
crease in clavaric acid production in minimal medium
containing asparagine/glutamate as nitrogen source as
compared to the untransformed strain (Figure 6) and no
significant reduction in medium with 30 mM ammonium
as nitrogen source. These results support the conclusion
that the squalene epoxidase encoded by erg1 is involved
in the conversion of squalene to epoxide-squalene during
clavaric acid biosynthesis.
Silencing of erg1 Results in a Partial
Requirement of Ergosterol
During the fermentation with the transformants carrying
the antisense RNA constructions, a clear reduction of
growth (measured as dry weight) was observed in the
transformants grown in asparagine/glutamate medium
(allowing expression of the antisense RNA), but not in
the medium with 30 mM ammonium (Figure 6C).
Growth of the transformants was only obtained if the
cultures of the transformants were supplemented with
12 mg/ml ergosterol (Figure 6D). In the static liquid cultures
of transformants in MM supplemented with ergosterol, the
growth was lower than that of the parental strain grown
under the same conditions (Figure 6D, right). In conclu-
sion, all evidence suggests that the squalene epoxidase
encoded by erg1 is required for clavaric acid production
and also for ergosterol biosynthesis.
Lanosterol Does Not Stimulate
Clavaric Acid Biosynthesis
Since lanosterol might serve as an intermediate in an alter-
native pathway for conversion of 2,3-oxidosqualene to
clavaric acid (Figure 1) the effect of lanosterol on clavaric
acid biosynthesis was studied both in the HS898SEa1-236, December 2007 ª2007 Elsevier Ltd All rights reserved 1337
Chemistry & Biology
Clavaric Acid Biosynthesis in HypholomaFigure 2. Conserved Motifs in the Squalene Epoxidases
(A) Promoter region upstream of the erg1 gene (starting at the ATG, in bold face). Relevant regulatory sequences recognized by different transcrip-
tional factors are shown in bold face (see text). The exons E-1 to E-6 are shown in boxes.
(B) Three conservedmotifs in the squalene epoxidase encoded by the erg1 gene ofH. sublateritium and the homologous genes of other fungi (see text
for details on the role of each one of the motifs). The numbers at the right of the HS sequence correspond to the position of these amino acids in the
H. sublateritium SE.
(C) Percentage of amino acid identity between pairs of fungal squalene epoxidases. HS,Hypholoma sublateritium; TR, Trichophyton rubrum; CI,Coc-
cidioides immitis; AO, Aspergillus oryzae; AF, Aspergillus fumigatus; EN, Emericella nidulans; NC, Neurospora crassa; MG,Magnaporthe grisea; CN,
1338 Chemistry & Biology 14, 1334–1346, December 2007 ª2007 Elsevier Ltd All rights reserved
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Clavaric Acid Biosynthesis in HypholomaFigure 3. Organization of the DNA Re-
gion around erg1 and Overexpression
of the Gene
(A) Organization of the three genes existing in
the 12.0 kb sequenced region of H. sublateri-
tium. The erg1 promoter and terminator re-
gions are shown in black.
(B) Plasmids used to construct the expression
vector pHgSEover; erg1 is expressed from
the A. bisporus gdh promoter. The hygromycin
resistance gene (hph) is expressed from the
A. bisporus gpd promoter. T35S, 35S cauli-
flower mosaic virus transcriptional terminator.
LB and RB, left border and right border
sequences of the Agrobacterium tumefaciens
T-DNA region.
(C)PCRof different transformants (lanes1 to13)
with primers SE14 (internal to erg1) and HPH4
(internal to the hph gene) to confirm the inte-
gration of the intact erg1 expression cassette.
Lane 14, untransformed H. sublateritium. Lane
15, size markers (in kb on the right).
(D) Southern hybridization using a 340 bp
probe internal to erg1 confirming the presence
of at least one additional copy of the erg1 gene
(different band sizes depending upon the
integration site). The endogenous erg1 copy
(3.0 kb) is indicated by an arrow on the right.
Size markers (lane 3) are indicated by arrows
on the left. Lanes 4, 5, and 6 show the profile
of the untransformed H. sublateritium strain.and HS898SEa2-4 transformants expressing the anti-
sense erg1 gene and in the wild-type strain.
Lanosterol (20 mg/ml) added to definedminimal medium
did not stimulate clavaric acid biosynthesis but clearly
reduced its production in all strains. The reduction in thewild-type was of 76%, whereas in both transformants, it
almost suppressed clavaric acid production (Table S1,
see the Supplemental Data available with this article on-
line). These results do not support an involvement of lano-
sterol as a direct precursor of clavaric acid and insteadCryptococcus neoformans; YL, Yarrowia lipolytica; SC, Saccharomyces cerevisiae; CA, Candida albicans. The first number in each square box
corresponds to the percentage of identical amino acids, and the second includes identical and functionally conserved ones.
Chemistry & Biology 14, 1334–1346, December 2007 ª2007 Elsevier Ltd All rights reserved 1339
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Clavaric Acid Biosynthesis in HypholomaFigure 4. Overexpression of erg1 and
Clavaric Acid Production in H. sublateri-
tium
(A) Northern hybridizations showing increased
expression of erg1 in transformants HS898SE
over-21 and HS898SEover-43 in MM with as-
paragine/glutamate, differences were smaller
in MM with 10 mM ammonium acetate and
30 mM ammonium acetate, respectively. Hy-
bridizations were performed with a 340 bp
probe internal to erg1 as indicated in Experi-
mental Procedures.
(B) Comparative levels of clavaric acid produc-
tion in cultures of H. sublateritium HS898 and
the transformants with the erg1 expression
cassette in MM with asparagine/glutamate,
10 mM ammonium acetate, or 30 mM ammo-
nium acetate, respectively. Static cultures
were grown for 15 days in triplicate. Vertical
lines on top of each bar indicate standard devi-
ation values of the mean of the three flasks.
Note the increased clavaric acid production
in the SEover-21 and SEover-43 strains in
asparagine/glutamate medium. Clavaric acid
producton is referred to that of the wild-type
(160 mg/ml = 100%).suggest that high levels of lanosterol exert a feedback
effect on some of the steps involved in biosynthesis of
the antitumor compound.
DISCUSSION
The cloned erg1 gene encodes a protein very similar to
other fungal SEs, particularly to those of basidiomycetes
Cryptococcus neoformans and Ustilago maydis and
mammalian cells, but they are more distantly related to
the SEs of ascomycetes [22]. The cloned H. sublateritium
erg1 gene contained five introns. The presence of rela-
tively large numbers of introns is frequent in other genes
of basidiomycetes [27]. In contrast, the erg1 gene of the
ascomycete T. rubrum contains a single intron [22, 28].
Squalene epoxidases (EC. 1.14.99.7) are flavoprotein
mono-oxygenases that catalyze the conversion of squa-
lene to (3S)2,3-oxidosqualene, which in mammals, is rate1340 Chemistry & Biology 14, 1334–1346, December 2007 ª20limiting in the biosynthesis of cholesterol and in yeast in
the biosynthesis of ergosterol [29]. In addition to oxygen,
the enzyme requires FAD, NADPH [29–31], NADPH-
cytochrome P450 reductase (EC. 1.6.2.4) [32], and a still
unknown protein factor existing in the cell supernatants
[33, 34]. The molecular mechanism of oxidation of squa-
lene has been studied by Abe and coworkers [29, 35].
The reduced form of the flavoprotein appears to react
with a molecular oxygen to produce a superoxide anion
that leads to the formation of flavin C(4a)-hydroperoxide
that may act then as an electrophile [35]. Finally, the oxy-
gen is transferred to the C-C-terminal double bond of
squalene.
Recent photoaffinity labeling [36, 37] and site-directed
mutagenesis studies [35] led to the identification of con-
served residues that play important roles in enzyme activ-
ity. These motifs are conserved in the H. sublaterium SE.
These include a Rossman fold consisting of alternating07 Elsevier Ltd All rights reserved
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Clavaric Acid Biosynthesis in HypholomaFigure 5. Silencing of the erg1 Gene by Antisense RNA
(A) Constructions pHgSEa1 and pBGSEa2 containing fragments of different size of erg1 in the opposite (30 to 50) orientation (for antisense RNA for-
mation). In both constructions, the erg1 antisense strand is expressed from the promoter of the A. bisporus gdhA promoter and is flanked by the gdhA
transcriptional terminator. The hygromycin resistance cassette and the LB and RB border sequences are as in the legend of Figure 3.
(B) Southern hybridizations showing the correct integration of the antisense cassettes in two transformants with each of the antisense constructions.
Lane 1, sizemarkers (indicated on the left, in kb). Lanes 2 and 3, transformants with pBGSEa2. Lane 4, control, untransformedH. sublateritium. Lanes
5 and 6, transformants with pHgSEa1. Hybridizations were performed with a 340 bp fragment internal to erg1. The endogenous erg1 gene corre-
sponds to the 6.5 kb hybridyzing band. Note the different size of the additional copy or copies of the antisense constructions in transformants
SEa2 as compared to transformants SEa1.a helices and b sheets that contains the Gly-X-Gly-X-X-
Gly sequence [38, 39] located in the C-terminal region of
the first b sheet (amino acids 14–19 in the H. sublateritium
Erg1 protein). A second motif Asp-Gly-X-X-Ser-X-Phe-
Arg that appears to interact with the pyrophosphate group
of FAD [40] is located at positions 172–179 of the H. sub-
lateritium Erg1. The thirdmotif Gly-Asp-X-X-Asn-Met-Arg-
His-Pro-Leu-Thr-X-X-Gly-Met located in the H. sublateri-Chemistry & Biology 14, 1334–134tium Erg1 at positions 301–315 is found in a variety of
flavoproteins and appears to interact with the ribityl moi-
ety of FAD [41]. These enzymes catalyze the stereospe-
cific conversion of squalene to (3S)2,3-epoxidosqualene.
The SE gene (erg1) of S. cerevisiae is known to be in-
volved in ergosterol biosynthesis and its overexpression
confers resistance to allylamines (terbinafine) [42]. In
Candida albicans, disruption of the erg1 gene caused6, December 2007 ª2007 Elsevier Ltd All rights reserved 1341
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Clavaric Acid Biosynthesis in HypholomaFigure 6. Expression of erg1, Growth, and Clavaric Acid Production
(A) Northern hybridizations showing expression of erg1 in two different transformants containing the antisense constructions SEa1 in MM containing
either asparagine/glutamate, 10 mM ammonium acetate, or 30 mM ammonium acetate, respectively. Hybridizations were performed with a 340 bp
probe internal to erg1. RNA samples were taken from cultures at 15 days.
(BandC)Clavaricacidproduction (specificyield) anddryweight instaticculturesof thesametransformantsandthecontrol straingrownunder theconditions
of (A). Cultures were performed in triplicate. Vertical bars on top of each column indicate the standard deviation values of the mean of the three cultures.
(D)Aspectofgrowth instaticcultures inMMsupplementedwith20mg/mlergosterolofa transformantSEa1-23with theantisenseconstructionpHgSEa1 (left)
as compared to the untransformed parental strain (right). Thegrowth of the transformantwith the antisense construction is dependent upon ergosterol sup-
plementation.1342 Chemistry & Biology 14, 1334–1346, December 2007 ª2007 Elsevier Ltd All rights reserved
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several antifungal drugs including terbinafine [43]. Simi-
larly, overexpression of the erg1 gene in H. sublateritium
increases the resistence to terbinafine.
The cloned H. sublateritium SE seems to be involved in
the biosynthesis of ergosterol and clavaric acid. Similarly,
the SE has been shown to be involved both in phytosterols
and bioactive triterpene saponins in Panax ginseng [44].
The similarity of the early steps of the ergosterol and
clavaric acid biosynthesis explains that the Erg1 protein
is common for both the clavaric acid and ergosterol bio-
synthesis. The isoprenoid pathway for both compounds
appears to be identical up to the (3S)2,3-oxidosqualene
(Figure 1). However, whereas the (3S)2,3-oxidosqualene
is used directly for lanosterol biosynthesis (transformed
later into ergosterol), the clavaric acid intermediate clavar-
inone requires another oxidation step at carbons 22, 23 to
form (3S,22S)2,3:22,23-dioxidosqualene. Dioxidosqua-
lene is a known precursor of onocerin, a plant secondary
metabolite. There is also a report suggesting that dioxi-
dosqualene may be a precursor of lanosterol in the ergos-
terol biosynthetic pathway [45]. The hydroxyl groups at
carbons 2,3 are retained as hydroxyl and keto groups
respectively, in the molecule of clavarinone, and the C-3
hydroxyl group is finally esterified with a 3-hydroxy-3-
methylglutaryl moiety in the clavaric acid. The two rounds
of epoxidation may be catalyzed by the Erg1 SE since the
same occurs in other organisms; e.g., partially purified SE
from pig liver converts 2,3-oxidosqualene to 2,3:22,23-
squalene dioxide [46]. The existence of a related enzyme
catalyzing the second oxidation steps in H. sublateritium
seems unlikely since the hybridization studies argue
against the presence of more than one allele of erg1 in this
basidiomycete. An alternative pathway for the conversion
of oxidosqualene to clavarinone involving lanosterol as an
intermediate (dashed lines in Figure 1) does not seem likely
since supplementation of the Hypholoma cultures with
lanosterol did not increase clavaric acid production. The
observed inhibitory effect of lanosterol indicates a feed-
back regulation of clavaric acid biosynthesis by this sterol.
The nitrogen source-regulated gdh promoter from
A. bisporus (cloned in this work; see Experimental Proce-
dures) proved to be an excellent promoter for overex-
pressing in Hypholoma either the antisense RNA or the
erg1 gene itself. Previously, we have reported that com-
monly used ascomycete promoters are not efficient for
gene expression in the basidiomycetes [47]. Unfortunately
the number of constitutive or regulable basidiomycete
promoters available for molecular genetics studies is
very low, and this is a serious limitation for progress in
our understanding of the biosynthesis of pharmacologi-
cally active secondary metabolites in mushrooms. The
good expression of the antisense RNA from the nitrogen
source-regulated A. bisporus gdh promoter allowed us
to silence partially the erg1 gene. The results of these ex-
periments proved that erg1 is involved in both ergosterol
and clavaric acid biosynthesis.
Overexpression of erg1 from the gdh promoter in aspar-
agine/glutamate medium led to a clear increase of clavaricChemistry & Biology 14, 1334–134acid specific production; only minor increments of pro-
duction were observed in the ammonium-based (repres-
sing) medium, thus confirming that the effect of erg1
amplification on clavaric acid production is directly corre-
lated to the level of expression of erg1.
Clavaric acid is a valuable natural product synthesized
in minute amounts by the wild-typeH. sublateritium strain.
The constructions overexpressing the erg1 gene are very
useful to obtain increased amounts of this antitumor drug.
SIGNIFICANCE
This study provides clear evidence for the involvement
of the squalene epoxidase encoded by the cloned erg1
gene in the biosynthesis of the antitumor compound
clavaric acid in the producer basidiomycete Hypho-
loma sublateritium. Basidiomycetes are very difficult
to manipulate at the molecular level. Genetic modifi-
cation of Hypholoma has been achieved by Agrobac-
terium tumefaciens mediated transformation. Silenc-
ing of the erg1 gene by antisense expression of erg1
DNA fragments resulted in a reduction of the specific
yield of clavaric acid and also in an ergosterol-depen-
dent growth of the transformants. These results sup-
port the conclussion that the erg1-encoded squalene
epoxidase is involved in both clavaric acid and ergos-
terol biosynthesis. Natural yields of clavaric acid are
very low. Overexpression of the erg1 gene in H. subla-
teritium resulted in a 32% to 97% increment of clavaric
acid production.
EXPERIMENTAL PROCEDURES
Microbial Strains and Culture Media
H. sublateritium ATCC74314 [6], a dikaryotic strain, was routinely
grown on solid MEA (20 g/l malt extract, 5 g/l peptone, 20 g/l glucose,
15 g/l agar) medium at 20C. To obtain arthrospores, the cultures were
grown on solid PDA medium (Difco, Detroit, Michigan) at 20C for 3
weeks and collected by scraping the surface with glass beads in sterile
water. Liquid H. sublateritium cultures were grown in 100 ml of MEA
broth at 20C and 200 rpm. For clavaric acid production studies or
transcriptional analysis,H. sublateritiumwild-type strain and the trans-
formants were grown in minimal medium (MM) (glucose, 20 g;
MgSO4$7H2O, 0.5 g; H2KPO4, 0.5 g; HK2PO4, 0.6 g; CuSO4$5H2O,
0.4 mg [1.6 mM]; MnCl2$4H2O, 0.09 mg; H3BO3, 0.07 mg; Na2-
MoO4$2H2O, 0.02 mg; FeCl3, 1 mg; ZnCl2, 3.5 mg; thiamin hydrochlo-
ride, 0.1mg; biotin, 5 mg; distilled water, up to 1 l) with different nitrogen
sources (asparagine-glutamate, 15 mM each or ammonium acetate
10 mM and 30 mM). Erlenmeyer flasks (250 ml) containing 50 ml me-
dium were inoculated with two agar plugs (each 0.25 cm2) cut out
from a colony grown on solid MEA medium. Incubation was carried
out at 20C under static conditions since previous studies revealed
that static incubations were optimal for clavaric acid production.
Escherichia coli LE392 was used as a host strain for propagation of
bacteriophages. All plasmid subcloning experiments were performed
in E. coli DH5a that was transformed with competent cells by standard
protocols [48]. Agrobacterium tumefaciens AGL1 was used as a host
strain for transformation in conjugation experiments.
Preparation of Ergosterol and Terbinafine
Ergosterol was prepared at a stock concentration of 12 mg/ml in
ethanol and Tween 80 (1:1, v/v). The solution was heated at 65C dur-
ing 5 min before using it. Terbinafine (TRB) (Terbinafina 250 mg, Teva6, December 2007 ª2007 Elsevier Ltd All rights reserved 1343
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concentration of 25 mg/ml and used at the final concentrations indi-
cated in the Results section.
DNA Procedures and Plasmids
All basic DNA methods were performed as described by Sambrook
et al. [48]. Genomic DNA from both wild-type and hygromycin-resis-
tant H. sublateritium transformants was obtained by freezing cells
from a 20 d liquid culture in liquid nitrogen and grounding the frozen
pellet to a fine powder in a mortar, as described previously [47].
A binary plasmid vector (8.5 kb), designated pHg3Zf, consisting of
a pBGgHg backbone [49] containing the hph gen, the CaMV 35S tran-
scriptional terminator, and the gpd promoter from A. bisporus, was
constructed. The polylinker (PvuII fragment) of the plasmid pGEM
3Zf(+) (Promega, Madison, WI) was used to replace a PvuII-SmaI
(egfp gene) fragment of plasmid pBGgHg (novel construction pHg3Zf).
In order to construct the expression vector pGDHA-SEover, inter-
mediate plasmid pGDHA was made by inserting the A. bisporus
gdhA promoter sequence (obtained by PCR amplification with primers
PGDHA-F and PGDHA-R containing SacI and partial SmaI restriction
sites, respectively) in the vector pGEM 3Zf(+) (Promega, Madison,
WI) previously digested with SacI and SmaI restriction endonucleases.
The intermediate plasmid pGDHA-SE was made by inserting the erg1
gene sequence obtained by PCR amplification (3.5 kb) with primers
RTSEF and EMBLF5, in the SmaI restriction site of the plasmid
pGDHA. Finally, pGDHA-SEover was constructed by inserting the cas-
sette containing the erg1 gene with the gdhA promoter from pGDHA-
SE (obtained by PCR amplification with primers PGDHA-F and
EMBLF5) by blunt-end ligation at the PvuII-SmaI site in the plasmid
pBGgHg [49] (Figure 3).
Antisense RNA Constructions
For the erg1 gene attenuation studies, plasmids pHg-SEa1 and pBG-
SEa2 contained a fragment of the erg1 gene of H. sublateritium in the
antisense position under control of theA. bisporus glutamate dehydro-
genase promoter (PgdhA) and the transcriptional terminator of the
same gene. The hygromycin resistance gene was used as a selectable
marker.
Intermediate plasmid pGDHA-2 was made by inserting the A. bispo-
rus gdhA transcriptional terminator region (obtained by PCR amplifica-
tion with primers TGDHA-F and TGDHA-R containing BamHI and par-
tial SmaI restriction sites, respectively) in the vector pGDHA previously
digested with SmaI and BamHI restriction endonucleases. The 800 bp
fragment of the erg1 gene used in the antisense construction pHg-
SEa1 was amplified by PCR with oligonucleotides SE4 and SE6. This
PCR product was cloned in the SmaI site of the plasmid pGDHA-2
to create the pGDHA-2SEa. Finally, pHg-SEa was constructed by
inserting the SacI-BamHI fragment containing the antisense cassette
of plasmid pGDHA-2SEa in the vector pHg3Zf, previously digested
with the same restriction endonucleases (Figure 3).
In order to construct vector pBG-SEa2, intermediate plasmid
pGDHA-4 was made by inserting the polylinker (PvuII fragment) of
the plasmid pGEM 5Zf(+) (Promega, Madison, WI) in the SmaI site
of the plasmid pGDHA-2. The 1600 bp fragment of erg1 gene used
in the antisense construction pBG-SEa2 was amplified by PCR with
oligonucleotides RTSEF and RTSER and cloned in the plasmid
pGEM-T Easy (Promega, Madison, WI). The plasmid obtained, desig-
nated pGEM-ERG1, was digested with the NotI restriction enzyme.
This fragment was subcloned in vector pGDHA-4 to obtain plasmid
pGDHA-4SEa. The HindIII fragment of this vector was refilled (Klenow
fragment of the DNA polymerase) and cloned in plasmid PvuII-
digested pBGgHg digested PvuII, to obtain plasmid pBG-SEa2
(Figure 5). Artrospores of H. sublateritium were transformed by the
A. tumefaciens-mediated method [47].
Genomic Library Construction and Screening
Genomic DNA from H. sublateritium ATCC74314 was partially di-
gested with Sau3A. DNA fragments (10 to 22 kb) were ligated into1344 Chemistry & Biology 14, 1334–1346, December 2007 ª20the BamHI site of the lambda phage vector EMBL3, followed by in vitro
packaging. Recombinant bacteriophage plaques of the genomic
library were screened by the PCR procedure of Vaiman [25] with oligo-
nucleotides SE1 and SE2 as primers.
Southern Blot Analysis
Southern blotting was performed by standard procedures [48]. Digox-
igenin labeling, hybridization, and detection were performed with the
Genius Kit (Roche Diagnostics). Hybridizations were performed at
42C with a 53 SSC solution containing 0.1% lauryl-sarcosine,
0.02% SDS, 40% formamide, and 2% blocking reagent. The hybrid-
ization signals were visualized with a chemiluminescent substrate for
alkaline phosphatase (CDP-Star), according to the manufacturer’s
(Roche) protocol. For Southern experiments, a 340-bp NcoI-XmnI
DNA fragment, internal to the erg1 gene, were used as probe.
Primers Used for Cloning and Sequencing the erg1
Gene of H. sublateritium
Three conserved flavin-binding sequence motifs were used to design
the primer pairs SE1 and SE2 according to the codon usage in filamen-
tous fungi. PCR amplifications were performedwith TaqDNA polymer-
ase (Promega,Madison,WI), using genomic DNA ofH. sublateritium as
template. The resulting 0.8 kb DNA fragment was sequenced to con-
firm the presence of the gene of interest and used as a probe to screen
the H. sublateritium genomic library.
PCR Analysis
The presence of the erg1 expression cassette (construction pGDHA-
Seover) in the transformants was confirmed by PCR with primers
SE14 (internal to the erg1 gene) and HPH4 (internal to the hygromycin
resistance hph gene in the cassette).
Attenuation of erg1 gene expression was studied by the antisense
RNA strategy. The presence of the intact attenuation cassettes
(pHg-SEa1 and pBG-SEa2) in the transformants was confirmed by
PCR with primers PGDHA-F and TGDHA-R; these primers correspond,
respectively, to theA. bisporus gdhApromoter and thegdhA terminator.
Inverse PCR (IPCR) was used for the rapid in vitro amplification of
DNA regions that flank a region of known erg1 sequence. The template
for the reverse primers was a mixture of EcoRV restriction fragments
that were circularized by self-ligation. For circularization, 50 ng of the
appropriate restriction fragment (2.8–3.5 kb) was diluted to a concen-
tration of 50 ng/ml in ligation buffer. The ligation reaction was allowed
to proceed for 10 hr at 16C. The PCRwas performed in reactions con-
taining 0.1 ng of NcoI digested circularized DNA, using one cycle
of 94C for 5 min, followed by 30 cycles of denaturation at 94C for
1.5 min, primer annealing at 55C for 1min, and extension by Taq poly-
merase (Promega, Madison, WI) at 70C for 4 min.
RNA Isolation and Northern Analysis
Total H. sublateritium RNA was isolated with the RNeasy kit (QIAGEN).
Northern analyses were performed by standard methods with 10 mg of
total RNA per lane. A 340 pbNcoI-XmnI fragment internal to theH. sub-
lateritium erg1 gene was labeled and used as the probe. Hybridizations
were carried out as described by Sambrook et al. [48]. The intensity of
the hybridizing bands was determined with the Quantity one 1D Anal-
ysis software (BioRad). A 666 bp SacI probe internal to theH. sublateri-
tium g-actin gene was used to estimate the total amounts of RNA in
gels.
Reverse Transcriptase-Polymerase Chain Reaction
cDNA was obtained from total RNA extracted from mycelia grown for
15–18 days in MEAmedium. To verify the presence of a putative intron
in the genomic DNA sequence, the region containing the expected in-
tron splice sites was amplified from RNA with platinum Taq polymer-
ase (SuperScript One-Step RT-PCR kit, Invitrogen, San Diego, CA),
by using the oligonucleotides EX1F and EX1R, EX2F and EX2R,
EX5F and EX5R, or EX2F and EX5R as primers. The PCR products ob-
tained were directly cloned in the pGEM-T Easy vector (Promega,07 Elsevier Ltd All rights reserved
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RNA samples were treated with RQ1 Rnase-Free Dnase (Promega,
Madison, WI).
Computer Analysis
Computer analysis of nucleotide and amino acid sequences was car-
ried out with the Lasergene DNASTAR programs, BLASTX2 and
BLASTN software packages (http://www.ncbi.nlm.nih.gov/BLAST/).
Multiple alignments were constructed with CLUSTALW (http://www.
ebi.ac.uk/tools/clustalw/). Putative conserved domains were detected
with PFAM (http://www.sanger.ac.uk/Software/Pfam/). The nucleotide
sequence ofH. sublateritium erg1 gene was deposited in the GenBank
database under accession number EF581376.
Clavaric Acid Analysis and Quantification
Samples of 15 ml taken from the cultures of H. sublateritium wild-type
and transformants were extracted twice with chloroform (60 ml) and
sulphuric acid 5% (50 ml) for 5 hr with shaking (220 rpm). The organic
extracts were pooled, concentrated to dryness in a vacuum evapora-
tor, and dissolved in methanol (1 ml). The organic solvent solutions
(200 ml) were derivatized according to the method of Garcı´a et al.
[50] and quantified by HPLC with pure clavaric acid as standard. The
chromatography was performed in a Shimadzu 10 AD-VP chroma-
tograph connected to a photodiode detector with a LiChrospher
100RP-18 (250 3 4 mm) 5 mm pore column. A mobile phase (flow of
0.7 ml/min) containing water:acetonitrile 95:5 (v/v) (solvent A) and
methanol:acetonitrile 95:5 (v/v) (solvent B) was used with a gradient
as follows: time zero 53% B, 13–18 min 89% B, 18–20 min 100% B,
and 25–30 min 53% B. Under these conditions, the retention time of
the clavaric acid was 21.4 min quantified at 254 nm. Standards of
the clavaric acid were provided by F. Pelaez (CIBE, Merck Sharp &
Dohme de Espan˜a).
Terbinafine Susceptibility Test
The analysis of the resistance to terbinafine was performed with a petri
dish growth assay where the growth of H. sublateritium and the erg1
overexpression transformants SEover-43 and SEover-21 was exam-
ined. Fresh 0.25 cm2 agar plug of a 10 day old culture grown on solid
MEAmediumwere plated onMMplates with 0, 2.5, 6.25, or 12.5 mg/ml
of terbinafine. The plates were incubated at 20C, and the growth was
estimated as previously described by Panagou et al. [51]. Images were
captured with a high-sensitivity Canon EOS 10D (DS6031) (Canon
USA, Inc., New York, USA) digital camera and processed with Image
Pro Express version 6.0 (Media Cybernetics) image-analysis software.
All plates were photographed every day. Each plate was corrected for
background by subtracting the image of an uninoculated (blank) plate
incubated together with the test plates. Imageswere 512 by 512 pixels.
Visible growth is expressed in integrated optical density (IOD) units.
Supplemental Data
Supplemental Data include one table on the effect of lanosterol on
clavaric acid production and are available at http://www.chembiol.
com/cgi/content/full/14/12/1334/DC1/.
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